---
title: "Sanofi: The drug SAR446597 has received FDA Fast Track designation"
description: "On July 16th, Sanofi announced that the U.S. Food and Drug Administration has granted SAR446597 Fast Track designation. This drug is a one-time intravitreal gene therapy for the treatment of geographi"
type: "news"
locale: "en"
url: "https://longbridge.com/en/news/248820917.md"
published_at: "2025-07-16T14:14:02.000Z"
---

# Sanofi: The drug SAR446597 has received FDA Fast Track designation

> On July 16th, Sanofi announced that the U.S. Food and Drug Administration has granted SAR446597 Fast Track designation. This drug is a one-time intravitreal gene therapy for the treatment of geographic atrophy secondary to age-related macular degeneration. The Fast Track designation process is designed to facilitate the development and expedite the review of drugs that treat serious conditions and fill unmet medical needs. The FDA established this program to help patients gain earlier access to important new drugs, covering a range of serious diseases

On July 16th, Sanofi announced that the U.S. Food and Drug Administration has granted SAR446597 Fast Track designation. This drug is a one-time intravitreal gene therapy for the treatment of geographic atrophy secondary to age-related macular degeneration. The Fast Track designation process is designed to facilitate the development and expedite the review of drugs that treat serious conditions and fill unmet medical needs. The FDA established this program to help patients gain earlier access to important new drugs, covering a range of serious diseases

### Related Stocks

- [SNYNF.US - Sanofi](https://longbridge.com/en/quote/SNYNF.US.md)
- [SNY.US - Sanofi](https://longbridge.com/en/quote/SNY.US.md)

## Related News & Research

| Title | Description | URL |
|-------|-------------|-----|
| Looking Into Altria Group Inc's Recent Short Interest | Altria Group Inc's short interest has decreased by 7.37%, with 44.24 million shares sold short, representing 2.64% of av | [Link](https://longbridge.com/en/news/276075820.md) |
| Artisan Partners Ltd Partnership Discloses 10.11% Stake In Pearson As Of 11 Feb, Says Filing | Pearson PLC :PEARSON PLC - HOLDING(S) IN COMPANYARTISAN PARTNERS LIMITED PARTNERSHIP DISCLOSES 10.11% STAKE IN PEARSON A | [Link](https://longbridge.com/en/news/276068264.md) |
| Sanofi: Beyfortus Study Shows Benefit For Infants Beyond First RSV Season | Sanofi announced that a study on its RSV immunization program using Beyfortus showed a significant reduction in RSV-rela | [Link](https://longbridge.com/en/news/276038221.md) |
| What To Expect From Analog Devices’s (ADI) Q4 Earnings | Analog Devices (ADI) will report Q4 earnings this Wednesday. Last quarter, it exceeded revenue expectations by 2.1%, wit | [Link](https://longbridge.com/en/news/276090818.md) |
| Olympics-Curling-World body returns to less stringent officiating after talks with NOCs | World Curling has reverted to less stringent officiating at the Winter Olympics after discussions with National Olympic  | [Link](https://longbridge.com/en/news/276011295.md) |

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.